NCT03689712 2023-10-24ROMAN: Phase 3 Trial Investigating the Effects of GC4419 on Radiation Induced Oral Mucositis in Head/Neck Cancer PatientsGalera Therapeutics, Inc.Phase 3 Completed455 enrolled 11 charts
NCT04529850 2022-08-16Ph 2 Open Label Study of GC4419 to Reduce SOM Associated With Chemoradiotherapy for Head and Neck CancerGalera Therapeutics, Inc.Phase 2 Completed38 enrolled 10 charts